A combination drug of abacavir‐lamivudine‐zidovudine (Trizivir®) for treating HIV infection and AIDS
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
The primary objective of this review will be to evaluate the antiviral efficacy of co‐formulated zidovudine‐lamivudine‐abacavir (Trizivir®) for initial treatment of HIV/AIDS. The secondary objectives will be to evaluate the safety and tolerability of the triple drug combination.